Download PDF
Thromb Haemost 1999; 82(01): 150-151
DOI: 10.1055/s-0037-1614646
Letters to the Editor
Schattauer GmbH

Recombinant Activated Factor VII for False Aneurysms in Patients with Normal Haemostatic Mechanisms

Andrew K. S. E. Liem
1   From the Department of Cardiothoracic Surgery, The Netherlands
,
Douwe H. Biesma
2   Department of Internal Medicine, The Netherlands
,
Sjef M. P. G. Ernst
3   Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
,
Marc A. A. M. Schepens
1   From the Department of Cardiothoracic Surgery, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 26 January 1999

Accepted 12 April 1999

Publication Date:
11 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Pressler V, McNamara JJ. Thoracic aortic aneurysm: natural history and treatment. J Thorac Cardiovasc Surg 1980; 79: 489-98.
    PubMedGoogle Scholar
  • 2 Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP. Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med 1994; 331: 1729-34.
    CrossrefPubMedGoogle Scholar
  • 3 Hedner U, Glazer S, Pingel K, Alberts KA, Blombäck M, Schulman S, Johnsson H. Successful use of recombinant factor VIIa in a patient with severe hemophilia A during synovectomy. Lancet 1988; ii: 1193
    PubMedGoogle Scholar
  • 4 Meijer K, Sieders E, Slooff MJH, de Wolf, van der Meer J. Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII. Thromb Haemost 1998; 80: 204-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Hedner U. Recombinant activated factor VII as a universal haemostatic agent. Blood Coag Fibrinol 1998; 9 (Suppl. 01) 147-52.
    PubMedGoogle Scholar
  • 6 Ten Cate H, Bauer KA, Levi M, Edgington TS, Sublett RD, Barzegar S, Kass BL, Rosenberg RD. The activation of factor X and prothrombin by recombinant factor VIIa is mediated by tissue factor. J Clin Invest 1993; 92: 1207-12.
    CrossrefPubMedGoogle Scholar